Associate Vice President – US Policy Campaigns
Eli Lilly
- Location
- Washington, DC
- Employment
- Full Time
- Work model
- On-Site
- Level
- Senior
- Posted
- Sep 21, 2026
About this role
At Lilly, the work is demanding because patients are waiting. We unite caring with discovery to help make life better for people around the world, knowing that every decision, every detail, and every day matters. Headquartered in Indianapolis, Indiana, our over 50,000 employees around the globe take on complex challenges to discover and deliver life-changing medicines, strengthen how health is understood and managed, and support the communities we serve. This is hard, urgent, selfless work—but it’s work worth doing. If you’re driven by purpose and ready to bring your best to work that truly matters for patients, we invite you to join us.
Position
Overview: As a Global Public Policy Leader with a focus on US policy, you will report to the VP, Head of US Policy and play a pivotal role in advancing policy priorities at the federal and state levels. You will oversee the development and execution of campaigns that enable Lilly to meet its policy goals and mitigate threats before they materialize. You will be action-oriented and outcomes-focused, with a primary responsibility for executing comprehensive policy campaigns to eliminate barriers in the external environment and improve the ecosystem in support of enterprise-wide policy priorities – working in close partnership with colleagues in Government Affairs, business units, and Lilly USA to advance the goals of the US Policy team. This position requires a keen understanding of US political dynamics, regulatory frameworks, communications, advocacy and a strategic mindset to drive business growth while ensuring compliance with local laws and regulations. At a high level, you will: Identify opportunities for strategic partnerships to support policy campaigns that advance US policy priorities. Identify opportunities to harness stakeholder engagement to create momentum for policymaker action in priority areas, such as price control mitigation, PBM reform, prevention policy and other areas as assigned. Execute plans to amplify key policy arguments and critical resources (e.g., white papers, advocacy briefs) with external stakeholders. Coordinate with business unit (therapeutic area) and Government Affairs teams to ensure alignment on activities that advance preferred policy outcomes in the US. Support the Head of US Policy by partnering with subject matter experts on the team to develop coordinated policy-shaping plans across a defined set of enterprise-wide policy goals.
Key Responsibilities
Identifying Policy Shaping Opportunities: Drive outcomes by developing and deploying the full array of tools, resources, analytics, and strategic partnerships. Influence development and oversee execution of comprehensive policy campaigns to drive progress on preferred policy outcomes. Develop cohesive policy narratives that make the case for redressing harms of emerging policy threats. Leverage strategic-thinking to develop tactics to create public support for policy change Other projects and emerging topics, as assigned. Communication and Stakeholder Engagement: Engage with internal and external stakeholders to build consensus around strategic actions and advocacy initiatives to create regulatory, legislative, or political momentum for desired policy changes. Lead and direct external consultants to support an integrated and strategic-minded approach to drive change within the policy ecosystem. Build support for the value of prescription drugs and efforts to rebuild public trust in science. Create action with internal stakeholders (Government Affairs, Communications, Legal, Business Units, Lilly USA) by incorporating feedback into strategic plans to advance policy goals. Coordinate with business unit (therapeutic area) corporate affairs teams to ensure alignment between short term and longer-term policy objectives and policy shaping efforts. Strategic Partnerships: Develop, influence, and direct diverse, multi-stakeholder coalitions that can articulate harms of policy threats and